Healint
Healint is a Singapore-based digital health company, acquired by Aptar Digital Health in February 2024, providing pharmaceutical and biotech firms with companion apps, connected drug delivery devices, and Software as a Medical Device solutions for chronic neurological and immunological conditions.
- Company typePrivate
- Founded2015
- HeadquartersSingapore, Singapore
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Healint does
Healint is a Singapore-based digital health company that develops software and connected device solutions for pharmaceutical and biotech companies to support patients with chronic neurological and immunological conditions. Following its February 2024 acquisition by Aptar Digital Health, a division of Aptar Pharma, Healint operates as a subsidiary within Aptar's digital health portfolio, which supports life sciences partners across 120 countries. The company was founded by Francois Cadiou and is led by a team including CTO Nicolas Paris and CMO Suasti Lye.
Healint firmographics
Firmographics- Name
- Healint
- Legal name
- Healint
- Website
- https://healint.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Healint is a Singapore-based digital health company, acquired by Aptar Digital Health in February 2024, providing pharmaceutical and biotech firms with companion apps, connected drug delivery devices, and Software as a Medical Device solutions for chronic neurological and immunological conditions.
- Ownership category
- akta.pro rank
Healint industry classification
Industry- Product category
- Digital Health Platform
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)
- akta.pro secondary industries
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
Keywords
Where Healint is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices1 record
Markets served
Healint business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Digital Health Platform & Solutions: B2B revenue model providing digital health solutions to pharmaceutical and medtech companies including companion apps, connected drug delivery devices, and Software as a Medical Device (SaMD). Solutions support the entire patient journey from treatment initiation to ongoing management.
- Study & Data Services: Leveraging user communities to run virtual clinical studies and generate real-world evidence on treatment usage for pharmaceutical partners.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Healint product offering
Product offeringCore offering
Healint builds and operates a certified digital health platform that delivers companion mobile apps (Migraine Buddy, Esme, Allergy Buddy), connected drug-delivery devices (HeroTracker Sense), Software as a Medical Device (SaMD) products, and Study & Data services for pharmaceutical and medtech partners. The platform supports the entire patient journey from treatment initiation through adherence and outcomes, and is used to generate real-world evidence and run virtual clinical studies across 120 countries.
Product overview
Healint was a digital health company focused on neurological conditions, particularly migraine management. Following its acquisition by Aptar Digital Health in February 2024, Healint's flagship product Migraine Buddy became part of Aptar's portfolio of companion apps and digital health solutions. Healint's offerings centered on migraine tracking and symptom management applications designed to help patients understand and communicate their condition to healthcare providers.
Differentiator
Problem solved
Functional benefit
Brands
- Migraine Buddy: A mobile application that helps people with migraine and headache disorders track symptoms, triggers, and treatments to better understand and communicate their condition.
Products and services
- Migraine Buddy
Quantifiable outcome
- 23.2% CAGR growth projected in digital therapeutics migraine market
- +1 more outcomes
Companies that use Healint
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles2 records
Healint technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Healint partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Enable InjectionscorePartnership to integrate Enable Injections' enFuse wearable drug delivery device with Aptar Digital Health's companion digital solution. The collaboration aims to enhance patient experiences by combining connected drug delivery with digital patient engagement capabilities.
- ŌURAcoreCollaboration to advance migraine insights by connecting Migraine Buddy app with Oura Ring wearable device. The integration allows users to correlate wearable biometric data with migraine symptoms and triggers for improved understanding and management.
- AstraZenecacoreLicensing agreement to develop AI-powered screening algorithms. The partnership leverages AstraZeneca's therapeutic expertise with Aptar Digital Health's digital health platform capabilities to create innovative screening solutions.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Healint competitors and assessment
Company assessmentDirect peers
- Click Therapeutics: Click Therapeutics develops prescription digital therapeutics and software-enhanced drug therapies, primarily through pharma partnerships (e.g., Otsuka). It competes with Healint for enterprise pharma digital health engagements across neurology and other therapeutic areas.
- WellDoc: WellDoc develops FDA-cleared digital health platforms and companion apps for chronic conditions (notably diabetes). It serves health systems, payors, and pharma with a regulated SaMD approach comparable to Healint's platform.
- Better Therapeutics: Better Therapeutics develops prescription digital therapeutics for cardiometabolic conditions, going through FDA review as a medical device. It pursues a pharma-partnered go-to-market comparable to Healint's companion app and SaMD model.
- Happify Health: Happify Health (now Twill) develops digital therapeutics and care platforms for mental health and chronic conditions, with pharma and payor partnerships. It overlaps with Healint on regulated DTx and patient engagement capabilities.
- Voluntis: Voluntis is a France-based SaMD platform that develops companion apps and digital therapeutics for oncology, diabetes, and other conditions, partnering with pharma companies. It is a direct peer to Healint and is now also part of Aptar Digital Health following its acquisition, making it the closest sibling in the portfolio.
- Sidekick Health: Sidekick Health is a digital therapeutics platform offering condition-specific companion apps across multiple therapeutic areas through partnerships with pharma and payors. It directly competes with Healint for pharma digital engagement contracts and therapeutic-area breadth.
- Kaia Health: Kaia Health develops digital therapeutics for musculoskeletal pain and chronic conditions, with employer and payor channels alongside pharma engagement. Its DTx focus on pain/MSK overlaps thematically with Healint's neurological chronic-condition portfolio.
- Akili Interactive: Akili Interactive is a prescription digital therapeutics company focused on cognitive neurology (ADHD, multiple sclerosis cognitive dysfunction). It serves pharma through prescription DTx distribution and partnership models similar to Healint's pharma enterprise motion.
- Medisafe: Medisafe is a medication adherence companion app platform with pharma partnerships. Its focus on adherence tracking and patient engagement for chronic conditions overlaps directly with Healint's Migraine Buddy and companion app offerings.
Emerging players
- Biofourmis: Biofourmis combines remote patient monitoring with AI-driven digital therapeutics, serving pharma and health systems. While its core is RPM-enabled care, its SaMD and pharma partnership motion overlaps with Healint's connected therapeutics and study/data services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Healint social profiles
Digital presenceHealint financial estimates
Financial estimateRevenue estimate
Valuation estimate
Healint leadership team
Management profileNumber of profiles
Profiles4 records
Healint funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Healint M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Healint
What does Healint do?
Healint builds and operates a certified digital health platform that delivers companion mobile apps (Migraine Buddy, Esme, Allergy Buddy), connected drug-delivery devices (HeroTracker Sense), Software as a Medical Device (SaMD) products, and Study & Data services for pharmaceutical and medtech partners. The platform supports the entire patient journey from treatment initiation through adherence and outcomes, and is used to generate real-world evidence and run virtual clinical studies across 120 countries.
Is Healint a public or private company?
Healint is a private company. It is classified as corporate owned and is currently acquired.
When was Healint founded?
Healint was founded in 2015. It employs 11 to 50 people.
Where is Healint based?
Healint is headquartered in Singapore, Singapore, in the Asia region.
How does Healint make money?
Two revenue lines are on record. Digital Health Platform & Solutions are the primary driver. The others are study & Data Services.
Who are Healint's main competitors?
Direct peers on record are Click Therapeutics, WellDoc, Better Therapeutics, Happify Health, Voluntis, Sidekick Health, Kaia Health, Akili Interactive and Medisafe. Biofourmis is listed as an emerging player.
Does Healint have an API?
No public API is recorded for Healint.
What industry is Healint in?
Healint's product category is Digital Health Platform. Its primary akta.pro industry code is HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 6219 and its SIC code is 8000.